About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

WITHDRAWNPhase 4NCT00168051

Study Comparing Blood Levels of ReFacto and Advante in Hemophilia A

The purpose of the study is to compare the pharmacokinetic parameters of ReFacto and Advate, using the chromogenetic substrate assay to measure plasma Factor VIII activity in plasma.

Lead sponsor: Wyeth is now a wholly owned subsidiary of Pfizer•4 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer

Age

18 - 64 years

Sex

MALE

Healthy Volunteers

No

Inclusion Criteria

•Severe hemophilia A
•Previously treated patients with at least 150 exposure days to any Factor VIII product

Exclusion Criteria

•Hypersensitivity to any recombinant Factor VIII product
•History of or current Factor VIII inhibitor
•Bleeding episode or other reason requiring Factor VIII treatment within 3 days of study

Related studies

ATHNdataset Registry

NCT06820515 · Hemophilia, Thrombosis, and more

RECRUITINGPhase 1/2

A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A

NCT07226206 · Hemophilia A

RECRUITINGPhase 1/2

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A

NCT05987449 · Hemophilia A

RECRUITINGPhase 3

SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis

NCT04563520 · Hemophilia A

National Longitudinal Cohort of Hematological Diseases

NCT04645199 · Multiple Myeloma, Acute Myeloid Leukemia, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 25, 2018Terms

Trial snapshot

StatusWITHDRAWN

PhasePHASE4

Enrollment—

Start dateApr 2005

Last updatedSep 25, 2018

Condition

Locations shown

Washington D.C., District of Columbia

Atlanta, Georgia

Iowa City, Iowa

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 25, 2018Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions